Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Añadir filtros








Intervalo de año
1.
Rev inf cient ; 100(5): 1-11, 2021. ilus
Artículo en Español | LILACS, CUMED | ID: biblio-1348797

RESUMEN

Introducción: El p-clorofenol alcanforado es un derivado clorofenólico de uso común como medicación intraconducto en Endodoncia. Son escasos los reportes científicos sobre sus efectos en la musculatura lisa vascular arterial y la regulación del flujo sanguíneo local. Objetivo: Determinar el efecto del p-clorofenol alcanforado sobre la dinámica contráctil del músculo liso vascular arterial en el tiempo. Método: Se realizó una investigación experimental preclínica utilizando 14 anillos de aorta obtenidos de ratas Wistar. Los anillos se colocaron en baño de órganos y se preactivaron con noradrenalina, registrándose luego la tensión desarrollada por el músculo liso vascular tras la adición de p-clorofenol alcanforado durante diferentes intervalos de tiempo. Resultados: El 51,4 porciento de la musculatura lisa vascular se relajó por la acción del p-clorofenol alcanforado. El mayor descenso del tono vascular se produjo entre el tercer y quinto minuto de añadido el medicamento. Las pruebas de Wilcoxon de los rangos con signos evidenciaron diferencias significativas entre la tensión base inicial y la registrada en los diferentes intervalos de tiempo estudiados. Conclusiones: el p-clorofenol alcanforado, induce in vitro, relajación del músculo liso arterial a través de un acoplamiento excitación-contracción de tipo farmacomecánico, la cual se incrementa en función del tiempo(AU).


Introduction: Camphorated p-chlorophenol is a chlorophenolic derivative commonly used as an intra-oral medication in endodontics. Scientific reports on its effects in arterial vascular smooth muscle and local blood flow regulation are scarce. Objective: To determine the effect of camphorated p-chlorophenol on the contractile dynamics of arterial vascular smooth muscle. Method: An experimental and preclinical research was conducted with the use of 14 aortic rings of Wistar rats. The rings were placed in an organ bath and preactivated with noradrenaline, and the tension developed by the vascular smooth muscle at different time intervals was recorded after induction of camphorated p-chlorophenol. Results: Most of the vascular smooth muscle (51.4 percent) relaxed with the use of camphorated p-chlorophenol. The greatest decrease in vascular tone occurred between the third and fifth minute after use the drug. Wilcoxon rank tests showed significant differences between tension observed at baseline and those recorded at the different time intervals studied. Conclusions: Camphorated p-chlorophenol, induces in vitro, relax the arterial smooth muscle through a pharmacomechanical excitation-contraction link, which increases according to the time(AU).


Introdução: O cânfora-clorofenol é um derivado clorofenólico comumente utilizado como medicamento intracanal em Endodontia. Relatórios científicos sobre seus efeitos no músculo liso vascular arterial e na regulação do fluxo sanguíneo local são escassos. Objetivo: Determinar o efeito da cânfora-clorofenol na dinâmica contrátil do músculo liso vascular arterial ao longo do tempo. Método: Foi realizada investigação experimental pré-clínica com 14 anéis aórticos obtidos de ratos Wistar. Os anéis foram colocados em banho de órgãos e pré-ativados com norepinefrina, em seguida, a tensão desenvolvida pela musculatura lisa vascular foi registrada após a adição de cânfora-clorofenol em diferentes intervalos de tempo. Resultados: 51,4 porcento dos músculos lisos vasculares estavam relaxados pela ação do cânfora-clorofenol. A maior diminuição do tônus vascular ocorreu entre o terceiro e o quinto minuto após a adição do medicamento. Os testes de Wilcoxon das faixas com sinais mostraram diferenças significativas entre a tensão base inicial e a registrada nos diferentes intervalos de tempo estudados. Conclusões: O cânfora-clorofenol induz, in vitro, relaxamento da musculatura lisa arterial por meio de um acoplamento excitação-contração do tipo farmacomecânico, que aumenta em função do tempo(AU).


Asunto(s)
Animales , Ratas , Clorofenoles/administración & dosificación , Músculo Liso Vascular/efectos de los fármacos , Tono Muscular/efectos de los fármacos , Ratas Wistar , Alemania
2.
Acta cir. bras ; 30(7): 484-490, 07/2015. graf
Artículo en Inglés | LILACS | ID: lil-754985

RESUMEN

PURPOSE: To study racemic bupivacaine, non-racemic bupivacaine and ropivacaine on myocardial contractility. METHODS: Isolated Wistar papillary muscles were submitted to 50 and 100 mM racemic bupivacaine (B50 and B100), non-racemic bupivacaine (NR50 and NR100) and ropivacaine (R50 and R100) intoxication. Isometric contraction data were obtained in basal condition (0.2 Hz), after increasing the frequency of stimulation to 1.0 Hz and after 5, 10 and 15 min of local anesthetic intoxication. Data were analyzed as relative changes of variation. RESULTS: Developed tension was higher with R100 than B100 at D1 (4.3 ± 41.1 vs -57.9 ± 48.1). Resting tension was altered with B50 (-10.6 ± 23.8 vs -4.7 ± 5.0) and R50 (-14.0 ± 20.5 vs -0.5 ± 7.1) between D1 and D3. Maximum rate of tension development was lower with B100 (-56.6 ± 38.0) than R50 (-6.3 ± 37.9) and R100 (-1.9 ± 37.2) in D1. B50, B100 and NR100 modified the maximum rate of tension decline from D1 through D2. Time to peak tension was changed with NR50 between D1 and D2. CONCLUSIONS: Racemic bupivacaine depressed myocardial contractile force more than non-racemic bupivacaine and ropivacaine. Non-racemic and racemic bupivacaine caused myocardial relaxation impairment more than ropivacaine. .


Asunto(s)
Animales , Masculino , Amidas/farmacología , Anestésicos Locales/farmacología , Bupivacaína/farmacología , Contracción Miocárdica/efectos de los fármacos , Bupivacaína/química , Depresión Química , Tono Muscular/efectos de los fármacos , Tono Muscular/fisiología , Contracción Miocárdica/fisiología , Músculos Papilares/efectos de los fármacos , Músculos Papilares/fisiología , Ratas Wistar , Valores de Referencia , Estereoisomerismo , Factores de Tiempo
3.
Biol. Res ; 48: 1-6, 2015. graf, tab
Artículo en Inglés | LILACS | ID: biblio-950792

RESUMEN

BACKGROUND: Ruta graveolens L. (R. graveolens) is a medicinal plant employed in non-traditional medicines that has various therapeutic properties, including anthelmintic, and vasodilatory actions, among others. We evaluated the trachea-relaxant effects of hydroalcoholic extract of R. graveolens against potassium chloride (KCl)- and carbachol-induced contraction of rat tracheal rings in an isolated organ bath. RESULTS: The results showed that the airway smooth muscle contraction induced by the depolarizing agent (KCl) and cholinergic agonist (carbachol) was markedly reduced by R. graveolens in a concentration-dependent manner, with maximum values of 109 ± 7.9 % and 118 ± 2.6 %, respectively (changes in tension expressed as positive percentages of change in proportion to maximum contraction), at the concentration of 45 µg/mL (half-maximal inhibitory concentration IC50: 35.5 µg/mL and 27.8 µg/mL for KCl- and carbachol-induced contraction, respectively). Additionally, the presence of R. graveolens produced rightward parallel displacement of carbachol dose-response curves and reduced over 35 % of the maximum smooth muscle contraction. CONCLUSIONS: The hydroalcoholic extract of R. graveolens exhibited relaxant activity on rat tracheal rings. The results suggest that the trachea-relaxant effect is mediated by a non-competitive antagonistic mechanism. More detailed studies are needed to identify the target of the inhibition, and to determine more precisely the pharmacological mechanisms involved in the observed biological effects.


Asunto(s)
Animales , Ratas , Parasimpatolíticos/farmacología , Tráquea/efectos de los fármacos , Extractos Vegetales/farmacología , Ruta/química , Músculo Liso/efectos de los fármacos , Fármacos Neuromusculares Despolarizantes/farmacología , Cloruro de Potasio/farmacología , Furocumarinas/análisis , Quercetina/análisis , Rutina/análisis , Tráquea/cirugía , Técnicas In Vitro , Carbacol/farmacología , Extractos Vegetales/química , Cromatografía Liquida , Ratas Sprague-Dawley , Colinérgicos/farmacología , Concentración 50 Inhibidora , Componentes Aéreos de las Plantas/química , Contracción Muscular/efectos de los fármacos , Tono Muscular/efectos de los fármacos
4.
Arq. neuropsiquiatr ; 67(1): 62-68, Mar. 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-509110

RESUMEN

We evaluated the safety and effectiveness of botulinum toxin A (BoNT/A) in the treatment of spasticity in 20 children with spastic diplegic cerebral palsy (CP). All the patients received injections in the gastrocnemius and soleus, and 15 received injections in the adductors. The total dose varied from 70 to 140 U (99.75±16.26 U), or 7.45±2.06 U/kg per patient. The treatment improved the patients' walking and gait pattern significantly. There was also a significant alteration in the heel-ground distance and increased motion of the ankle joint. These structural changes in the feet were sustained until the end of the follow-up, although the same was not observed for the functional parameters. Three patients complained of weakness in the lower limbs. In conclusion, BoNT/A is safe and effective when used in a single session of injections and produces a sustained structural modification of the lower limbs. However, functional changes are temporary and are only observed during the peak effect of the drug.


Para avaliação da segurança e eficácia do tratamento com toxina botulínica A (TB-A) na espasticidade na paralisia cerebral (PC), foram selecionadas 20 crianças com a forma diplegia espástica. Todos os pacientes receberam injeções nos gastrocnêmios e sóleos, 15 receberam doses nos adutores da coxa. A dose total variou de 70 a 140 Us (99,75±16,26 U), 7,45±2,06 U/Kg por paciente. O tratamento com a TB-A melhorou significativamente a deambulação e o padrão de marcha. Houve também significativa alteração da distância tornozelo-solo e aumento da amplitude de movimento da articulação do tornozelo. Essas mudanças estruturais dos pés se mantiveram até o final do acompanhamento. O mesmo não foi observado com parâmetros funcionais. Três pacientes apresentaram fraqueza em membros inferiores. Conclui-se que a TB-A, em uma única aplicação, é segura e eficaz. Há modificação sustentada da estrutura motora dos membros inferiores, porém mudanças funcionais são temporárias, durante o pico de ação do medicamento.


Asunto(s)
Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Toxinas Botulínicas Tipo A/administración & dosificación , Parálisis Cerebral/tratamiento farmacológico , Fármacos Neuromusculares/administración & dosificación , Parálisis Cerebral/complicaciones , Estudios de Seguimiento , Marcha/efectos de los fármacos , Extremidad Inferior/fisiopatología , Espasticidad Muscular/tratamiento farmacológico , Tono Muscular/efectos de los fármacos , Estadísticas no Paramétricas , Resultado del Tratamiento
5.
Egyptian Rheumatology and Rehabilitation. 2009; 36 (1): 97-108
en Inglés | IMEMR | ID: emr-100945

RESUMEN

To evaluate the therapeutic effect of intramuscular injection of Botox A on children with mild to moderate shortening of tendoachillis. Forty children were involved in this study, the age ranged from 1 and 2/12 year and 2 and 7/12 years with mean age I and 7/12 +/- 4/12 years. Patients were divided into two equal groups. Patients of the first group had mild tightness, and subdivided into 2 groups A and B, each included JO cases. Group A was treated by Botox injection, while group B received other physical modalities without Botox injection. The second group had moderate tightness and subdivided into two groups [C and D], each included 10 cases. Group C received two Botox injections [once every 3 months] while group D received other physical modalities. Each group was monthly evaluated up to 6 months, by modified Ashworth scale, patients' global response Btx A treatment, ankle ROM, pain score, and walking time. Results: There was high percentage of improvement in groups A and C in pain score, kinetic score, tenderness, and walking score. The percentage of improvement was less in group B and D. Botox A intramuscular injection in the calf muscles of children with mild to moderate tightness tendoachillis had good effects to decreasing pain. tenderness and muscle tone


Asunto(s)
Humanos , Masculino , Femenino , Tono Muscular/efectos de los fármacos , Terpenos , Toxinas Biológicas , Niño , Inyecciones Intramusculares
6.
Indian J Physiol Pharmacol ; 2005 Oct-Dec; 49(4): 403-10
Artículo en Inglés | IMSEAR | ID: sea-106682

RESUMEN

The pulmonary-renal cascade may regulate the respiration and skeletal muscle contractility. To evaluate this working hypothetical model, we conducted experiments to ascertain the skeletal muscle tone of the Swiss mice (20-35 g). The animals were evaluated for their skeletal muscle tone via several techniques i.e. inclined plane test, grip strength test and swim test. Groups of mice (n=6) were pre-treated with mefenamic acid (60 mg/kg, i.p), carbenoxolone (100 mg/kg i.p) or vehicle only 15 minutes before the treatment with heparin (500 U/kg, i.v), urokinase (5500 U/kg, i.v) and erythropoietin (150 U/kg, i.v). Heparin potentiated the loss of skeletal muscle tone induced by mefenamic acid and carbenoxolone while urokinase & erythropoietin significantly enhanced the skeletal muscle tone as evaluated by all or one of the tests. Other groups of mice (n=6) were pretreated with mefenamic acid (1 mg i.c.v), carbenoxolone (160 microg i.c.v) or minoxidil (30 microg i.c.v) and the effects of heparin & urokinase and erythropoietin on skeletal muscle tone were evaluated. To study the effects of heparin and urokinase on nerve regeneration, two groups of mice underwent a sham and sciatic nerve crush procedure. The mice treated with urokinase recovered much faster as compared to those treated with heparin or saline. These experimental results suggest that gap junction blockers and potassium channel openers interact with heparin, urokinase and erythropoietin to control the skeletal muscle tone.


Asunto(s)
Animales , Antiinflamatorios no Esteroideos/farmacología , Antiulcerosos/farmacología , Anticoagulantes/farmacología , Carbenoxolona/farmacología , Femenino , Fuerza de la Mano/fisiología , Heparina/farmacología , Inyecciones Intraventriculares , Riñón/efectos de los fármacos , Pulmón/efectos de los fármacos , Masculino , Ácido Mefenámico/farmacología , Ratones , Minoxidil/farmacología , Tono Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Compresión Nerviosa , Activadores Plasminogénicos/farmacología , Nervio Ciático/fisiología , Transducción de Señal/efectos de los fármacos , Natación/fisiología , Activador de Plasminógeno de Tipo Uroquinasa/farmacología , Vasodilatadores/farmacología
7.
Biol. Res ; 37(3): 395-403, 2004. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-394434

RESUMEN

The primary clinical symptom of Paralytic Shellfish Poisoning is acute paralytic illness produced by paralyzing toxins. Paralytic shellfish poison is formed by a mixture of phycotoxins and their toxicity is due to its reversible binding to a receptor site on the voltage-gated sodium channel on excitable cells, thus blocking neuronal transmission. We studied the effect of the gonyautoxin 2/3 epimers by local infiltration in the anal internal sphincter of healthy voluntary adults in order to reduce anal tone. The toxin was injected after prior clinical evaluation, anoscopy and anorectal manometry. Post injection clinical examination, electromyography and anorectal manometry were performed. Resting and voluntary contraction pressures were measured and the anorectal inhibitory and anocortical reflexes were tested by manometry. Blood and urine samples were obtained from each participant, and hemogram, basic metabolic panel, and urinalysis were done both before and one week after the injection. This study shows, for the first time, that gonyautoxin 2/3 reduces the anal tone by relaxing the anal sphincters in 100 % of the participants. Manometric recordings showed a significant decrease in anal maximal voluntary contraction pressure after the toxin injection, dropping to 55.2 ± 6.2 % and 47.0 ± 6.8 % (Mean Value ± Std.Dev.) of the baseline values at 2 minutes and at 24 hours respectively after the injection. Post-injection electromyography showed that activity of the muscle was abolished. We conclude that local administration of gonyautoxin 2/3 to the anal sphincter produces immediate relaxation and a statistically significant decrease in the anal tone (p <0.001)..


Asunto(s)
Humanos , Masculino , Adulto , Persona de Mediana Edad , Canal Anal/efectos de los fármacos , Relajantes Musculares Centrales/farmacología , Relajación Muscular/efectos de los fármacos , Tono Muscular/efectos de los fármacos , Saxitoxina/farmacología , Electromiografía , Inyecciones Intramusculares , Manometría
8.
Biol. Res ; 32(1): 29-33, 1999. tab, graf
Artículo en Inglés | LILACS | ID: lil-241340

RESUMEN

The underlying mechanisms of acetycholine-induced intestinal relaxation in the lizard Liolaemus tenuis tenuis are still unknows. By using a classical model of intestinal recording of isometric contraction and relaxation in conjunction with specific pharmacological tools, this article studies the possible influence of EDRF/NO and nicotinic ganglionar receptors on the Ach-induced relaxation in an effort to elucidate the probable mechanisms involved in ACh effect. It was observed that the relaxation of the lizard intestine elicited by ACh (10(-7) - 4 x 10(-4) M) was not affected by hexametonium (5 x 10(4) M) or tetrodotoxin (10(-6) M). Nicotine (10(-7) to 10(-4) M) induced relaxation was significantly antagonized by hexametonium; however, it was not influenced by tetrodotoxin. These results allow us to discard a neuronal pathway in cholinergic-induced relaxation, suggesting a more direct cholinergic effect on the smooth muscle, perhaps mediated by an unknown substance released by some specialized tissue. N-nitro-L-arginine, used to block NO-synthase and NO production, induced no changes in ACh-induced relaxation. Methylene blue, a soluble guanylate cyclase inhibitor, induced no changes in ACh-induced relaxation. These results allow us to dicard a probable role of EDRF/nitric oxide in the ACh-induced relaxation of lizard small intestine, providing evidence that this mechanism could be different from reported on other species.


Asunto(s)
Animales , Masculino , Femenino , Agonistas Colinérgicos/farmacología , Esófago/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Relajación Muscular/efectos de los fármacos , Tono Muscular/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Hexametonio/farmacología , Lagartos , Azul de Metileno/farmacología , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , Antagonistas Nicotínicos/farmacología , Óxido Nítrico Sintasa , Nitroarginina/farmacología , Tetrodotoxina/farmacología
9.
Medicina (B.Aires) ; 58(2): 135-40, 1998. ilus, tab
Artículo en Español | LILACS | ID: lil-212784

RESUMEN

Se presenta una serie de 7 pacientes con SIDA en quienes se diagnosticó poliradiculomielopatía causada por Citomegalovirus (CMV-PRAM), con el objetivo de evaluar la eficacia del tratamiento con ganciclovir, foscarnet, o la combinación de ambos agentes. Se realizaron evaluaciones clínicas y neurológicas al momento de presentación y durante el tratamiento para el CMV. La fuerza muscular fue establecida de acuerdo a la escala del Medical Research Council (MRC). Se clasificó la respuesta al tratamiento de acuerdo al grado de mejoría en la fuerza muscular. En 6 de los 7 pacientes se observó una mejoría en la fuerza muscular con tratamiento anti-CMV alcanzando grado 4, o una mejoría de por lo menos 3 grados de acuerdo a la escala MRC. El paciente restante tuvo una respuesta intermedia. CMV-PRAM puede ser tratada con ganciclovir o la combinación de ganciclovir y foscarnet con buenos resultados.


Asunto(s)
Adulto , Femenino , Humanos , Infecciones Oportunistas Relacionadas con el SIDA/complicaciones , Antivirales/uso terapéutico , Infecciones por Citomegalovirus/complicaciones , Foscarnet/uso terapéutico , Ganciclovir/uso terapéutico , Polirradiculopatía/tratamiento farmacológico , Polirradiculopatía/microbiología , Enfermedades de la Médula Espinal/tratamiento farmacológico , Enfermedades de la Médula Espinal/microbiología , Antivirales , Ensayos Clínicos como Asunto , Infecciones por Citomegalovirus/tratamiento farmacológico , Quimioterapia Combinada , Electromiografía , Foscarnet , Ganciclovir , Tono Muscular/efectos de los fármacos , Resultado del Tratamiento , Retención Urinaria/tratamiento farmacológico , Retención Urinaria/microbiología
10.
Braz. j. med. biol. res ; 30(5): 675-8, May 1997. ilus, graf
Artículo en Inglés | LILACS | ID: lil-196682

RESUMEN

Human skinned muscle fibers were used to investigate the effects of bovine serum albumin (BSA) on the tension/pCa relationship and on the functional properties of the Ca2+- release channel of the sarcoplasmic reticulum (SR). In both fast-and slow-type fibers, identified by their tension response to pSr 5.0, BSA (0.7-15 muM) had no effect on the Ca2+ affinity of the contractile proteins and elicited no tension per se in Ca2+-loaded fibers. In contrast, BSA (>1.0 muM) potentiated the caffeine induced tension in Ca2+-loaded fibers, this effect being more intense in slow-type fibers. Thus, BSA reduced the threshold caffeine concentration required for eliciting detectable tension, and increased the amplitude, the rate of rise and the area under the curve of caffeine-induced tension BSA also potentiated the tension elicited in Ca2+-loaded fibers by low-Mg2+ solutions containing 1.0 mM free ATP. These results suggest that BSA modulates the response of the human skeletal muscle SR Ca2+-release channel to activators such as caffeine and ATP.


Asunto(s)
Humanos , Adenosina Trifosfato/farmacología , Cafeína/farmacología , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio/efectos de los fármacos , Estimulantes del Sistema Nervioso Central/farmacología , Técnicas In Vitro , Fibras Musculares Esqueléticas/efectos de los fármacos , Tono Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Neurotransmisores/farmacología , Albúmina Sérica Bovina/farmacología
11.
Indian J Physiol Pharmacol ; 1996 Jan; 40(1): 23-8
Artículo en Inglés | IMSEAR | ID: sea-107873

RESUMEN

The effect of intracellular pH perturbations on the portal vein preparations of spontaneously hypertensive rats and their control Wistar Kyoto rats was investigated. Intracellular alkalinity induced by application of 20 mM NH4Cl or 20 mM trimethylamine produced dilatation of both preparations. Intracellular acidity induced by washout of the previous ammonium and trimethylamine solutions or by application of 20 mM sodium propionate solution caused constriction of both preparations. These responses of the portal veins of both animals to intracellular pH variations were qualitatively the same in nonactivated preparations and in preparations precontracted with 26 mM K+ or 1 microM norepinephrine. Recovery from acidic constrictions induced by washout of ammonium and trimethylamine solutions was significantly slower in spontaneous hypertensive rats than in Wistar Kyoto rats preparations. Conceivably, a lower intracellular pH in the vascular smooth muscle of the resistance vessels of hypertensive patients, as compared to normotensive individuals, may partly account for the hypertensive phenomena.


Asunto(s)
Cloruro de Amonio/farmacología , Animales , Concentración de Iones de Hidrógeno , Hipertensión/genética , Metilaminas/farmacología , Tono Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Norepinefrina/farmacología , Vena Porta/efectos de los fármacos , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WKY , Vasoconstrictores/farmacología
12.
Indian J Physiol Pharmacol ; 1995 Oct; 39(4): 421-2
Artículo en Inglés | IMSEAR | ID: sea-107864

RESUMEN

Neuropharmacological effects (Spontaneous locomotor activity, forced locomotor activity and anticonvulsant activity) of invermectin were studied at 400, 800 and 1600 micrograms/kg (administered, subcutaneously). Spontaneous locomotor activity was reduced at all the dose levels but forced locomotor activity was slightly reduced at 800 and 1600 micrograms/kg. The drug did not exhibit any anticonvulsant potential at any of the dose levels studied.


Asunto(s)
Animales , Antihelmínticos/farmacología , Anticonvulsivantes/farmacología , Conducta Animal/efectos de los fármacos , Sistema Nervioso Central/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Electrochoque , Ivermectina/farmacología , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Tono Muscular/efectos de los fármacos
16.
Indian J Physiol Pharmacol ; 1976 Jul-Sep; 20(3): 153-5
Artículo en Inglés | IMSEAR | ID: sea-106629

RESUMEN

2,4-dichlorophenoxy acetic acid (2,4-D) produces myotonia in healthy animals. The action of this drug was studied on smooth muscles in vitro using isolated strips of rabbit's duodenum. The drug was found to have a stimulant action on the smooth muscle. The action seems to be a direct one.


Asunto(s)
Ácido 2,4-Diclorofenoxiacético/farmacología , Animales , Duodeno/efectos de los fármacos , Contracción Muscular/efectos de los fármacos , Tono Muscular/efectos de los fármacos , Músculo Liso/efectos de los fármacos , Conejos , Estimulación Química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA